LION - フィデリティ・サザン （Fidelity Southern Corporation）

Reata Pharmaceuticals (RETA) +175% Pharmaceuticals up 192% on Friedreich''s ataxia drug omaveloxolone approval.OncoSec Medical (ONCS) +94%. Lionheart III (LION) +53%

Source: Dmitry Demidovich/ShutterStock.com The world of special purpose acquisition companies (SPACs) is about to get an exciting new member. Blank-check company Lionheart III Corp (NASDAQ: LION ) is rising today as momentum builds for its merger with Australia-based security software solutions company Security Matters . LION stock surged earlier today and, although it has since lost some momentum, shares remain firmly in the green. As of this writing, LION stock is up more than 10% for the day. Meanwhile, SMX — Security Matters’ stock ticker on the Australian Securities Exchange — is up 14%, having enjoyed a day of steady growth. Clearly, the market is eagerly anticipating the successful SPAC merger of this company. Does this mean that LION will continue to rise as investors wait for further merger updates? Let’s take a closer look at the market today and assess the forces pushing up shares. What’s Happening With LION Stock? What’s important to remember is that Lionheart’s successful merger agreement isn’t breaking news.

Gainers Motorsport Games Inc. (NASDAQ: MSGM ) shares rose 121% to $47.48 in pre-market trading after jumping over 710% on Tuesday. The company announced a debt-for-equity exchange with Motorsport Network. Also, Investor Mike Zoi reported purchase of 338,983 shares of Motorsport Games at an average price of $2.95 per share in Form 4 Filing. Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX ) shares rose 67% to $2.77 in pre-market trading after gaining around 10% on Tuesday. TransCode Therapeutics, Inc. (NASDAQ: RNAZ ) rose 42.5% to $1.07 in pre-market trading after the company reported preclinical results with immunotherapy candidate TTX-RIGA in melanoma. Wearable Devices Ltd. (NASDAQ: WLDS ) shares rose 39.2% to $1.10 in pre-market trading after gaining around 20% on Tuesday. Genetic Technologies Limited (NASDAQ: GENE ) rose 35.2% to $1.23 in pre-market trading. Genetic Technologies is forming strategic alliance with Qiagen, Reuters reported. Lionheart III Corp (NASDAQ: LION ) rose 30.2% to $13.50 in pre-market trading after dropping over 10% on Tuesday.